MannKind | Cassa E Equivalenti



Cash And Equivalent Cambiamento Data
Adma Biologics USD 103.15M 16.44M 2024-12
Dynavax Technologies USD 95.88M 23.45M 2024-12
Eli Lilly USD 3.27B 100.6M 2024-12
Halozyme Therapeutics USD 115.85M 38.47M 2024-12
Insmed USD 555.03M 93.58M 2024-12
MacroGenics USD 182.84M 3.22M 2024-12
MannKind USD 46.34M 16.03M 2024-12
Merck USD 13.24B 1.35B 2024-12
Novo Nordisk 57.02B 4.2B 2024-09
Pfizer USD 1.04B 49M 2024-12
Sanofi 6.8B 1.92B 2024-06
Xencor USD 40.88M 11.84M 2024-12



MannKind Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.